Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT (clinicaltrials.gov) - May 14, 2026 - P2 | N=50 | Recruiting | Sponsor: Baptist Health South Florida | Not yet recruiting ➔ Recruiting
Enrollment open • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|